GAIN THERAPEUTICS, INC Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GAIN THERAPEUTICS, INC stock issued during period, value, new issues for the quarter ending 2023-09-30 was $157.03K.
- GAIN THERAPEUTICS, INC stock issued during period, value, new issues for the quarter ending 2023-06-30 was $2.22M.
- GAIN THERAPEUTICS, INC stock issued during period, value, new issues for the quarter ending 2023-03-31 was $770.52K.
- GAIN THERAPEUTICS, INC stock issued during period, value, new issues for the quarter ending 2021-03-31 was $40.61M, a 3564.47% increase year-over-year.
- GAIN THERAPEUTICS, INC stock issued during period, value, new issues for fiscal 2020 was $177.00.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-09-30 | $157.03K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.22M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $770.52K 10-Q · filed 2024-05-14 | |
| 2021-03-31 | $40.61M 10-Q · filed 2022-05-16 | $40.60M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $177.00 10-K · filed 2022-03-25 |
| 2020-09-30 | $177.00 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$10.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | |
| 2020-03-31 | $1.11M 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |